Therefore, the EGFR target therapy has been applied in various epithelial tumors such as lung cancer (Lynch et al., 2004, Hirsch et al., 2008), colorectal cancer (Gibson et al., 2006), and head and neck cancer (Sundvall et al., 2010). This evidence concerns the gene EGFR and lung carcinoma.